Tag: NeVa VS
Vesalio gains two new neurovascular CE marks and expanded US FDA...
Vesalio has announced CE-mark certification and the European commercial launch of two new neurovascular devices—Neva VS for the treatment of cerebral vasospasm following aneurysmal...
Vesalio announces successful initial use of NeVa VS device in USA
Vesalio has announced the successful initial use of its NeVa VS device in the USA for the treatment of post-aneurysmal subarachnoid haemorrhage (aSAH) cerebral...
Vesalio announces US FDA approval of NeVa VS to treat cerebral...
Vesalio has announced US Food and Drug Administration (FDA) humanitarian device exemption (HDE) approval for commercialisation of its NeVa VS device, which is indicated...
